|
1
|
Auffinger B, Spencer D, Pytel P, Ahmed AU
and Lesniak MS: The role of glioma stem cells in chemotherapy
resistance and glioblastoma multiforme recurrence. Expert Rev
Neurother. 15:741–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sancho-Martinez I and Martin-Villalba A:
Tyrosine phosphorylation and CD95: A FAScinating switch. Cell
Cycle. 8:838–842. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eisele G, Roth P, Hasenbach K, Aulwurm S,
Wolpert F, Tabatabai G, Wick W and Weller M: APO010, a synthetic
hexameric CD95 ligand, induces human glioma cell death in vitro and
in vivo. Neuro Oncol. 13:155–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Konkankit VV, Kim W, Koya RC, Eskin A, Dam
MA, Nelson S, Ribas A, Liau LM and Prins RM: Decitabine
immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte
targeting through the Fas/Fas ligand pathway. J Transl Med.
9:1922011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao JX, Liu XQ and Dong BJ: Primary study
of bevacizumab combined with temozolomide for recurrent glioma.
Chin Clin Oncol. 39:920–922. 2011.
|
|
6
|
Do N, Weindl G, Grohmann L, Salwiczek M,
Koksch B, Korting HC and Schäfer-Korting M: Cationic
membrane-active peptides-anticancer and antifungal activity as well
as penetration into human skin. Exp Dermatol. 23:326–331. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loud JT, Peters JA, Fraser M and Jenkins
J: Applications of advances in molecular biology and genomics to
clinical cancer care. Cancer Nurs. 25:110–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hopkins AL and Groom CR: The druggable
genome. Nat Rev Drug Discov. 1:727–730. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okada M, Sato A, Shibuya K, Watanabe E,
Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T and
Kitanaka C: JNK contributes to temozolomide resistance of stem-like
glioblastoma cells via regulation of MGMT expression. Int J Oncol.
44:591–599. 2014.PubMed/NCBI
|
|
10
|
Sze CI, Su WP, Chiang MF, Lu CY, Chen YA
and Chang NS: Assessing current therapeutic approaches to decode
potential resistance mechanisms in glioblastomas. Front Oncol.
3:592013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Silber JR, Bobola MS, Blank A and
Chamberlain MC: O(6)-methylguanine-DNA methyltransferase in glioma
therapy: Promise and problems. Biochim Biophys Acta. 1826:71–82.
2012.PubMed/NCBI
|
|
12
|
Xu JJ, Hong UQ, Zhao W, Hong J, Wen N,
Ling QI and Liu XJ: Induction of broccoli polypeptide on apoptosis
of C6 glioma cells. Jilin Daxue Xuebao. 39:8–11. 2013.
|
|
13
|
O'Reilly MS, Holmgren L, Shing Y, Chen C,
Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J:
Angiostatin: A novel angiogenesis inhibitor that mediates the
suppression of metastases by a Lewis lung carcinoma. Cell.
79:315–328. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferguson SD: Malignant gliomas: Diagnosis
and treatment. Dis Mon. 57:558–569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cobbs CS: Cytomegalovirus and brain tumor:
Epidemiology, biology and therapeutic aspects. Curr Opin Oncol.
25:682–688. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dubrez L, Berthelet J and Glorian V: IAP
proteins as targets for drug development in oncology. Onco Targets
Ther. 9:1285–1304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartuzi P, Hofker MH and van de Sluis B:
Tuning NF-κB activity: A touch of COMMD proteins. Biochim Biophys
Acta. 1832:2315–2321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang YQQY, Bai X, Lu XD and Tan Y: Effects
of Survivin antisense oligonucleotides on proliferation of hepatic
cell line SMMC-7721. Jilin Daxue Xuebao. 39:278–281. 2013.
|
|
19
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stuckey DW and Shah K: TRAIL on trial:
Preclinical advances in cancer therapy. Trends Mol Med. 19:685–694.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fink MY and Chipuk JE: Survival of
HER2-positive breast cancer cells: Receptor signaling to apoptotic
control centers. Genes Cancer. 4:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dabbagh A and Rajaei S: The role of
anesthetic drugs in liver apoptosis. Hepat Mon. 13:e131622013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adrain C and Martin SJ: The mitochondrial
apoptosome: A killer unleashed by the cytochrome seas. Trends
Biochem Sci. 26:390–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Velde C Vande, Cizeau J, Dubik D, Alimonti
J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic
control of necrosis-like cell death through the mitochondrial
permeability transition pore. Mol Cell Biol. 20:5454–5468. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bo Sun, Jiajing Liu, Jiajun Chen, et al:
Experiment studies of novel tumstatin on C6 glioma cells in vitro.
Chin J Lab Diag. 20:707–709. 2016.
|
